BVMF
ODPV3
Market cap1.29bUSD
Feb 23, Last price
12.24BRL
1D
-0.08%
1Q
5.88%
Jan 2017
-2.86%
IPO
628.57%
Name
Odontoprev SA
Chart & Performance
P/E
12.37
P/S
2.92
EPS
0.99
Div Yield, %
7.62%
Shrs. gr., 5y
-1.33%
Rev. gr., 5y
4.75%
Revenues
2.28b
+7.67%
Net income
539m
+5.45%
CFO
605m
+45.94%
Dividend
Dec 19, 20250.23591 BRL/sh
Earnings
Feb 26, 2026
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Odontoprev S.A. provides private dental plans in Brazil and internationally. The company operates through Corporate, Small and Medium-Enterprise, Individual, and Other segments. It manages and sells dental care plans to corporations and/or individuals; provides commercial advisory, consulting, and business management services; and develops and licenses software programs. The company also retails and wholesales dental equipment and products, sanitizers, drugs, medicines, pharmaceutical inputs, and related items; offers warehousing, storage, loading, organization, custody of goods, technical, and administrative programming services, as well as general management of goods and business; and provides services of collecting, sending or delivering mail, documents, and objects or goods. In addition, it offers services related to accidents, diseases, and health insurance; and financial, and commercial and risk management services. The company was founded in 1987 and is headquartered in Barueri, Brazil. Odontoprev S.A. is a subsidiary of Bradesco Saúde S.A.
Valuation
Title BRL in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||